<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-SRB-H-IPHS-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Maintaining Low HIV Prevalence in the Republic of Serbia - Serbia (01-Jan-2026-31-Dec-2028)</narrative>
    </title>
    <description type="1">
      <narrative>Serbia, HIV, Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Strenghtening sustainability and transition of HIV prevention in Serbia. Objectives: Sustainability of community based HIV preventive services and introduction of innovative approaches; Stenghtening laboratory system for HIV; Strenghtening sustainable M&amp;E system.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="15" role="2" crs-channel-code="12004">
      <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
    </participating-org>
    <participating-org type="15" role="4" crs-channel-code="12004">
      <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
    </participating-org>
    <other-identifier ref="SRB-H-IPHSP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2026-01-01" />
    <activity-date type="2" iso-date="2026-01-01" />
    <activity-date type="3" iso-date="2028-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Olga Avdeeva</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>olga.avdeeva@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="RS" percentage="100">
      <narrative>Serbia</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="54.2">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="45.8">
      <narrative>HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="8.17">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="5.2">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="7.14">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="21.06">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="2.64">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="1.59">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="23.18">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="57ef74d8-840a-4792-b7d8-0c12163d7d91" percentage="0.99">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Biosafety and biosecurity, infrastructure and equipment</narrative>
        </description>
      </budget-item>
      <budget-item code="19ae85a9-12db-4fb8-9313-84f9feef29a0" percentage="11.15">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="5.81">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="a964bfef-7776-4f8c-bf11-c2f904336a18" percentage="0.48">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="3.38">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="9.21">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">884005.08</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">868621.91</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2028-01-01" />
      <period-end iso-date="2028-12-31" />
      <value currency="USD" value-date="2028-01-01">489713.72</value>
    </budget>
    <capital-spend percentage="17.04" />
    <transaction ref="113bae56-7762-4234-ad7d-c69a17c3e023">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-26" />
      <value currency="USD" value-date="2026-02-26">572175.00</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dfe484c2-aed2-4545-bf97-b7cf582c1fa7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-03" />
      <value currency="USD" value-date="2026-03-03">332495.85</value>
      <description>
        <narrative>Global Fund disbursement to SRB-H-IPHSP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b58e6c05-d74b-4a76-9882-1c5c0ec4f79b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">47754.09</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="67d018ec-40c8-4f47-9960-8fc57024f2c9">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-17" />
      <value currency="USD" value-date="2026-06-17">119120.94</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5122f718-f3f5-4679-a366-f808f90a7529">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-24" />
      <value currency="USD" value-date="2026-06-24">166680.62</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cde0d96d-8517-440a-8e18-03eb539b47e8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-24" />
      <value currency="USD" value-date="2026-06-24">-119120.94</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53afa029-177c-4cf5-b31b-53863d2c3837">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">179041.01</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bc1e5686-4264-4e60-803e-1a7feabf04b7">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">-166680.62</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="079a9c16-74eb-4819-81bb-ec32dd5fcbb5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">40664.85</value>
      <description>
        <narrative>Global Fund disbursement to SRB-H-IPHSP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="086bb509-c455-48c5-805d-8b173e684d38">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-08" />
      <value currency="USD" value-date="2026-09-08">37970.11</value>
      <description>
        <narrative>Global Fund disbursement to SRB-H-IPHSP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2fe2e1f8-d95c-498b-abc0-02526f9dac89">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">6709.00</value>
      <description>
        <narrative>Global Fund disbursement to SRB-H-IPHSP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="87c205d5-9fe9-4358-acfe-816d9e2639b4">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">997.09</value>
      <description>
        <narrative>Funds returned to the Global Fund from SRB-H-IPHSP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e153d591-4fc4-46cd-a345-3ebdb8034a96">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">316920.02</value>
      <description>
        <narrative>Global Fund disbursement to SRB-H-IPHSP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b6f7ee50-324c-4aaa-9f23-b8f4a569ef71">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">316920.02</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="59c1d0b2-6ebe-4e40-af6b-c55d665b93b3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">-997.09</value>
      <description>
        <narrative>Global Fund commitment to SRB-H-IPHSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="30747463-4bce-480a-8889-6aef6693bc23">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-20" />
      <value currency="USD" value-date="2026-10-20">8093.02</value>
      <description>
        <narrative>Global Fund disbursement to SRB-H-IPHSP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="acc30471-20b4-483d-b0a8-0995a4653aff">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-20" />
      <value currency="USD" value-date="2026-10-20">34270.49</value>
      <description>
        <narrative>Global Fund disbursement to SRB-H-IPHSP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Institute of Public Health of Serbia "Dr Milan Jovanovic Batut"</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/SRB-H-IPHS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/SRB/2025/HIV/en/SRB-H_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2025 - Funding Request - Window 7 - HIV - Serbia - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1685-SRB-H.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2025-02-17" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of 564,230EUR (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.1(1)(a) and 6.1(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a)  progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b)  increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in Commitment Letter "Ministry of Health of the Republic of Serbia, Letter of Commitment to fulfill the requirements and scale up preventive services in period 2026-2028", dated 4 February 2025 (the “Commitment Letter”), unless otherwise agreed in writing by the Global Fund: (a)  fulfil a total minimum co-financing commitment of EUR 1,293,068 from 2026-2028 (inclusive), comprising investments in HIV of 1,293,068 EUR (b)  fulfil the programmatic commitments as stipulated in Section 1.3 of the Commitment Letter; and (c)  provide to the Global Fund, by no later than 29 December of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i.  the approved annual budget for HIV for the upcoming year; and ii.  the total expenditure for HIV in the previous fiscal year</narrative>
      </condition>
      <condition type="3">
        <narrative>2 - The procurement of Health Products shall be carried out through the Pooled Procurement Mechanism (“PPM”) of the Global Fund, unless the Global Fund directs the Principal Recipient otherwise in writing. The Principal Recipient has all the necessary power and authority to execute, deliver and carry out its obligations under the wambo.org – PPM registration letter in the form approved by the Global Fund.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - Transition Plan In accordance with the STC Policy, by 30 June 2026, the Principal Recipient, in collaboration with the CCM, shall submit to the Global Fund and obtain the Global Fund’s prior written approval of, a detailed costed transition plan which assumes a transition away from Global Fund financing by the end of the Implementation Period (the “Transition Plan”). The Transition Plan shall: a) Set out a phased approach to transition the financing of key program components including human resources, procurement of essential medicines and health commodities, and services for key and vulnerable populations, to domestic funding sources by the end of the Implementation Period; (b) Identify and address policy and regulatory barriers to effective implementation, including but not limited to, national approval processes for new products (e.g., dual HIV/syphilis rapid diagnostic tests, new PrEP formulations, and self-testing kits); and (c) Detail measures to strengthen the capacity of relevant government authorities and HIV-focused NGOs for: (i) social contracting; (ii) service costing to inform budget allocations; (iii) identification and allocation of national and sub-national budget lines for NGO service procurement; and (iv) accreditation and licensing of NGO-delivered services. The Transition Plan shall also demonstrate progress in strengthening the social contracting mechanism and include a commitment to complete the transition of NGO-led HIV services to government funding by the end of the Implementation Period, thereby ensuring the sustainability of such services.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of individual HIV self-test kits distributed</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of individual HIV self-test kits distributed</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="0" />
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="500" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="700" />
        </period>
        <period>
          <period-start iso-date="2028-01-01" />
          <period-end iso-date="2028-12-31" />
          <target value="2000" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="21.94">
          <comment>
            <narrative>Numerator: 13166; Denominator: 60000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="24">
            <comment>
              <narrative>Numerator: 14400; Denominator: 60000.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="26.25">
            <comment>
              <narrative>Numerator: 15750; Denominator: 60000.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2028-01-01" />
          <period-end iso-date="2028-12-31" />
          <target value="27.75">
            <comment>
              <narrative>Numerator: 16650; Denominator: 60000.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="422" />
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="1500" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="2500" />
        </period>
        <period>
          <period-start iso-date="2028-01-01" />
          <period-end iso-date="2028-12-31" />
          <target value="4000" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="24.37">
          <comment>
            <narrative>Numerator: 14620; Denominator: 60000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="26.67">
            <comment>
              <narrative>Numerator: 16000; Denominator: 60000.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="29.17">
            <comment>
              <narrative>Numerator: 17500; Denominator: 60000.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2028-01-01" />
          <period-end iso-date="2028-12-31" />
          <target value="30.83">
            <comment>
              <narrative>Numerator: 18500; Denominator: 60000.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>